Revenio Group Oyj
OMXH:REG1V
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/E
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Valuation Scenarios
If P/E returns to its 3-Year Average (37.8), the stock would be worth €25.46 (85% upside from current price).
| Scenario | P/E Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 20.5 | €13.8 |
0%
|
| 3-Year Average | 37.8 | €25.46 |
+85%
|
| 5-Year Average | 42.7 | €28.74 |
+108%
|
| Industry Average | 18.9 | €12.73 |
-8%
|
| Country Average | 21.1 | €14.2 |
+3%
|
Forward P/E
Today’s price vs future net income
| Today's Market Cap | Net Income | Forward P/E | ||
|---|---|---|---|---|
|
€508.7m
|
/ |
Jan 2026
€17.4m
|
= |
|
|
€508.7m
|
/ |
Dec 2026
€22.7m
|
= |
|
|
€508.7m
|
/ |
Dec 2027
€28m
|
= |
|
|
€508.7m
|
/ |
Dec 2028
€31.7m
|
= |
|
|
€508.7m
|
/ |
Dec 2029
€38.9m
|
= |
|
Forward P/E shows whether today’s P/E still looks high or low once future net income are taken into account.
Peer Comparison
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| FI |
R
|
Revenio Group Oyj
OMXH:REG1V
|
367.1m EUR | 20.5 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
161.2B USD | 56.4 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
158.6B USD | 25.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
120.5B USD | 37.1 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
101.9B USD | 22.1 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
84.8B USD | 23.8 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.2B USD | 43 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
44.1B USD | 41.7 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
38.3B EUR | 18.2 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
41.4B USD | 23.5 | |
| US |
|
Resmed Inc
NYSE:RMD
|
30.9B USD | 20.8 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 16.2 |
| Median | 21.1 |
| 70th Percentile | 31.7 |
| Max | 232.7 |
Other Multiples
Revenio Group Oyj
Glance View
Revenio Group Oyj is a globally operating health technology, which engages in the detection of glaucoma, osteoporosis, skin cancer, and asthma. The company is headquartered in Vantaa, Etela-Suomen and currently employs 184 full-time employees. The company went IPO on 2003-01-01. The Company’s activities are divided into two business areas: Revenio Health Tech, which is responsible for the design, manufacture and sale of tonometers and bone density measurement devices; as well as Revenio Technology and Services, which provides contact center services for material handling systems. The company distributes products in a range of countries, including the United States, Canada, Australia, Japan and India. Furthermore, the Company is a parent of Done Medical Oy, Kauhajoen Sisalogistiikka Oy, Icare Finland Oy, Oscare Medical Oy and Midas Touch Oy, among others.
